Original news and analysis on international IP policy
It is “misleading” and “counter-productive” to assert that a pharmaceutical company’s filing for a patent on a HIV/AIDS drug in India will limit access to the drug in the future, GlaxoSmithKline said in response to an objection submitted today in…
Two Indian HIV/AIDS networks and an international group of lawyers today submitted a protest to the first application for a patent for an HIV/AIDS drug filed in India. The opportunity to stage a “pre-grant opposition” is the “beauty of the…
By Dugie Standeford for Intellectual Property Watch Editor’s Note: The National Assembly adopted the legislation on 21 March by a vote of 286 in favour and 193 against. It will now go to the Senate in May, according to reports.…
By Martin Vaughan for Intellectual Property Watch WASHINGTON, DC – Public health activists are condemning recent terms agreed to by Colombia, Peru and Central American countries in bilateral trade negotiations with the United States, that bind those countries to offer…
By Steve Gibb for Intellectual Property Watch WASHINGTON, DC – The director of the US National Institute of Environmental Health Sciences (NIEHS) is facing overwhelming opposition to a plan to privatise an open-access environmental science journal NIEHS publishes, according to…
PRAGUE – Les groupes industriels pro-brevets, qui ont investi des sommes considérables pour influencer les débats au sein de l’Europe sur un projet de directive – finalement rejeté – en matière de brevetabilité des inventions mises en oeuvre par ordinateur,…
Swiss pharmaceutical company Roche has launched a new initiative under which it says it will offer manufacturers in least developed countries technical assistance in producing generic HIV/AIDS medicines, but it is unclear how many companies will be able to benefit…
Prague — Patent-dependent industries that spent heavily for lobbying on a failed directive on the patentability of computer-related inventions are learning from their mistakes as they prepare for the possible resurrection of the issue. Lobbyists attending a Progress and Freedom…
A United States law firm representing public health groups filed suit against the US government on 14 December for a failure to be consulted by industry-heavy government advisory groups on trade policy. The case was filed in US District Court…
Members of the United States House of Representatives visited Geneva this week to learn more about ongoing trade negotiations and policy related to the possible avian influenza pandemic. The bipartisan group of Republicans and Democrats met on 28 November with…